Rat chemokine CXCL11: Structure, tissue distribution, function and expression in cardiac transplantation models

Molecular and Cellular Biochemistry

Volumn 296, Issue 1-2, 2007, Pages 1-9

  Mitsuhashi, Noboru ^a,c,d   Wu, Gordon D ^b   Zhu, Hui ^b   Kearns Jonker, Mary ^a   Cramer, Donald V ^a   Starnes, Vaughn A ^a   Barr, Mark L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CHIBA UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokine; CXCL11; CXCR3; Heart; I TAC; Inflammation; Rejection; SCYA11; Transplantation

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; CXC CHEMOKINE RECEPTOR 3; CXCL11 CHEMOKINE; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CD4+ T LYMPHOCYTE; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; CHEMOTAXIS; CYTOLOGY; GENETICS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; RAT; SEQUENCE ALIGNMENT; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; CHEMOKINES, CXC; CHEMOTAXIS; COS CELLS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, CHEMOKINE; SEQUENCE ALIGNMENT; TISSUE DISTRIBUTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 34447512971     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9010-9     Document Type: Article

References (49)

1. Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242, 2000
2. Mellado M, Rodriguez-Frade JM, Manes S, Martinez AC: Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol 19: 397-421, 2001
3. Proudfoot AE: Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2: 106-115, 2002
4. Sallusto F, Mackay CR, Lanzavecchia A: The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18: 593-620, 2000
5. Hancock WW, Gao W, Faia KL, Csizmadia V: Chemokine and their receptors in allograft rejection. Curr Opin Immunol 12: 511-516, 2000
6. El-Sawy T, Fahmy NM, Fairchild RL: Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol 14: 562-568, 2002
7. Duquesnoy RJ, Demetris AJ: Immunopathology of cardiac transplant rejection. Curr Opin Cardiol 10: 193-206, 1995
8. DeVries ME, Ran L, Kelvin DJ: On the edge: the physiological and pathophysiological role of chemokine during inflammatory and immunological responses. Semm Immunol 11: 95-104, 1999
9. Nelson PJ, Krensky AM: Chemokines, chemokine receptors, and allograft rejection. Immunity 14: 377-386, 2001
10. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S, Forster R, Lipp M, Lanzavecchia A: Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 29: 2037-2045, 1999
11. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187: 129-134, 1998
12. Widney DP, Xia YR, Lusis AJ, Smith JB: The murine chemokine CXCL11 (IFN-inducible T cell alpha chemoattractant) is an IFN-γ - and lipopolysaccharide-inducible glucocorticoid-attenuated response gene expressed in lung and other tissues during endotoxemia. J Immunol 164: 6322-6331, 2000
13. Zhang Y, Luxon BA, Casola A, Carofalo RP, Jamaluddin M, Brasier AR: Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 75: 9044-9058, 2001
14. Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, Willemze R, Tensen CP: Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 194: 398-405, 2001
15. Singh UP, Singh S, Iqbal N, Weaver CT, McGhee JR, LillardJWJr: IFNgamma-inducible chemokines enhance adaptive immunity and colitis. J Interferon Cytokine Res 23: 591-600, 2003
16. Nance S, Cross R, Fitzpatrick E: Chemokine production during hypersensitivity pneumonitis. Eur J Immunol 34: 677-685, 2004
17. Zhao DX, Hu Y, Miller GG, Luster AD, Mitchell RN, Libby P: Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol 169: 1556-1560, 2002
18. Lazzeri E, Lasagni L, Serio M, Romagnani S, Romagnani P: Cytokines and chemokines in nephropathies and renal transplant. G Ital Nefrol 19: 641-649, 2002
19. Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Li K, Ross DJ, Strieter RM: Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 169: 1037-1049, 2002
20. Hancock WW, Wang L, Ye Q, Han R, Lee I: Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 15: 479-486, 2003
21. Mitsuhashi N, Kearns-Jonker M, Wu GD, Bowdish ME, Jin YS, Mencel R, Zahorsky-Reeves J, Fischer-Lougheed J, Weinberg KI, Starnes VA, Cramer DV: Identification, functional analysis and expression in a heterotopic heart transplant model of CXCL9 in the rat. Immunology 112: 87-93, 2004
22. Cramer DV, Chapman FA, Jaffee B, Jones EA, Makowka L: Inhibition of the pyrimidine biosynthetic pathway with S-8660, an analogue of brequinar sodium, prolongs cardiac allograft survival in rats. J Heart Lung Transplant 12: 140-146, 1993
23. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, LinW, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K: Interferoninducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187: 2009-2021, 1998
24. Laich A, Meyer M, Werner ER, Werner-Felmayer G: Structure and expression of the human small cytokine B subfamily member 11 (SCYB11/formerly SCYB9B, alias I-TAC) gene cloned from IFN-γ - treated human monocytes (THP-1). J Interferon Cytokine Res 19: 505-513, 1999
25. Meyer M, Erdel M, Duba HC, Werner ER, Werner-Felmayer G: Cloning, genomic sequence, and chromosome mapping of Scyb11, the murine homologue ofSCYB11(aliasβR1/H174/SCYB9B/I-TAC/IP-9/CXCL11). Cytogenet Cell Genet 88: 278-282, 2000
26. Breathnach R, Chambon P: Organization and expression of eukaryotic split genes coding for proteins. Annu Rev Biochem 50: 349-383, 1981
27. Meyer M, Hensbergen PJ, van der Raaij-Helmer EM, Brandacher G, Margreiter R, Heufler C, Koch F, Narumi S, Werner ER, Colvin R, Luster AD, Tensen CP,Werner-Felmayer G: Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection. Eur J Immunol 31: 2521-2527, 2001
28. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F: HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 186: 139-146, 1997
29. Mack M, LuckowB, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Stangassinger M, Borlat F, Wells TN, Schlondorff D, Proudfoot AE: Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med 187: 1215-1224, 1998
30. Mohan K, Ding Z, Hanly J, Issekutz TB: IFN-γ -inducible T cell α chemoattractant is a potent stimulator of normal human blood T lymphocyte transendothelial migration: differential regulation by IFN-γ and TNF-α. J Immunol 168: 6420-6438, 2002
31. McColl SR, Mahalingam S, Staykova M, Tylaska LA, Fisher KE, Strick CA, Gladue RP, Neote KS, Willenborg DO: Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with otherCXCR3ligands. Lab Invest 84: 1418-1429, 2004
32. Nomiyama H, Mera A, Ohneda O, Miura R, Suda T, Yoshie O: Organization of the chemokine genes in the human and mouse major clusters of CC and CXC chemokines: diversification between the two species. Genes Immun 2: 110-113, 2001
33. Rat Genome Sequencing Project Consortium, Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428: 493-521, 2004
34. Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, Luster AD: Differential expression of three T lymphocyte-activating CXC 1041-1050, 1999
35. Cox MA, Jenh CH, Gonsiorek W, Fine J, Narula SK, Zavodny PJ, Hipkin RW: Human interferon-inducible 10-kDa protein and human interferoninducible T cell α chemoattractant are allotropic ligands for human CXCR3: differntial binding to receptor states. Mol Pharmacol 59: 707-715, 2001
36. Xanthou G, Williams TJ, Pease JE: Molecular chatacterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation. Eur J Immunol 33: 2927-2936, 2003
37. + T cells. J Leukoc Biol 68: 568-574, 2000
38. Romagnani P, Annunziato F, Lasagni L, Lazzeri E, Beltrame C, Francalanci M, Uguccioni M, Galli G, Cosmi L, Maurenzig L, Baggiolini M, Maggi E, Romagnani S, Serio M: Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 107: 53-63, 2001
39. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P: An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 197: 1537-1549, 2003
40. DeVries ME, Hosiawa KA, Cameron CM, Bosinger SE, Persad D, Kelvin AA, Coombs JC, Wang H, Zhong R, Cameron MJ, Kelvin DJ: The role of chemokines and chemokine receptors in alloantigenindependent and alloantigen-dependent transplantation injury. Semin Immunol 15: 33-48, 2003
41. Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, King JA, Smiley ST, Ling M, Gerard NP, Gerard C: Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 192: 1515-1520, 2000
42. Miura M, Morita K, Kobayashi H, Hamilton TA, Burdick MD, Strieter RM, Fairchild RL: Monokine induced by IFN-γ is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol 167: 3494-3504, 2001
43. Jiankuo M, Xingbing W, Baojun H, Xiongwin W, Xhuoya L, Ping X, Yong X, Anting L, Chunsong H, Feili G, Jinquan T: Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft. J Immunol 170: 1556-1565, 2003
44. Fahmy NM,Yamani MH, Starling RC, Ratliff NB,Young JB, McCarthy PM, Feng J, Novick AC, Fairchild RL: Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation 75: 72-78, 2003
45. Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majumder S, Ransohoff RM: Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and equisite regulation. Immunol Rev 177: 52-67, 2000
46. Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, Libby P, Plutzky J, Luster AD: Peroxisome proliferators-activated receptorgamma activators inhibit IFN-gamma-induced expression of the T cellactive CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol 164: 6503-6508, 2000
47. Proost P, Verpoest S, Van De Borne K, Schutyser E, Struyf S, Put W, Ronsse I, Grillet B, Opdenakker G, Van Damme J: Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferongamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids. J Leukoc Biol 75: 777-784, 2004
48. Carr A, Samaras K, Chisholm DJ, Cooper DA: Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351: 1881-1883, 1998
49. Kopp EB, Medzhitov R: The Toll-receptor family and control of innate immunity. Curr Opin Immunol 11: 13-18, 1999